Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
The company plans to begin a phase I/II study soon, which will evaluate the immunogenicity and safety of the vaccine candidate in adults aged between 18 and 29 years. Sanofi decided to begin the phase I/II study after the chlamydia vaccine candidate demonstrated promising results in pre-clinical studies. Caused by the bacterium Chlamydia trachomatis chlamydia is a common bacterial infection of the reproductive tract that can lead to infertility and pregnancy complications. The vaccine candidate is being developed to protect against primary genital tract infection and reinfection by the bacterium Shares of Sanofi have rallied 15% year to date compared with the industry's increase of 4.5%. Image Source: Zacks Investment Research Sanofi possesses one of the world's leading vaccine operations, with total annual sales of more than €5 billion in the past five years. The company's Vaccines unit has delivered mid-to-high-single-digit sales growth since 2018. In 2024, Sanofi's V
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Sanofi: Information concerning the total number of voting rights and shares - November 2025 [Yahoo! Finance]Yahoo! Finance
- Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals [Yahoo! Finance]Yahoo! Finance
- Regeneron: The Turnaround Is Gaining Steam [Seeking Alpha]Seeking Alpha
- Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovationGlobeNewswire
SNY
Sec Filings
- 12/22/25 - Form 6-K
- 12/15/25 - Form 6-K
- 12/12/25 - Form 6-K
- SNY's page on the SEC website